BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14680975)

  • 41. TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study.
    Coon H; Singh N; Dunn D; Eckfeldt JH; Province MA; Hopkins PN; Weiss R; Hunt SC; Leppert MF;
    Atherosclerosis; 2004 Jun; 174(2):357-62. PubMed ID: 15136067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fine mapping of Hyplip1 and the human homolog, a potential locus for FCHL.
    Pajukanta P; Bodnar JS; Sallinen R; Chu M; Airaksinen T; Xiao Q; Castellani LW; Sheth SS; Wessman M; Palotie A; Sinsheimer JS; Demant P; Lusis AJ; Peltonen L
    Mamm Genome; 2001 Mar; 12(3):238-45. PubMed ID: 11252174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the beta3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemia.
    Pihlajamäki J; Rissanen J; Valve R; Heikkinen S; Karjalainen L; Laakso M
    Metabolism; 1998 Nov; 47(11):1397-402. PubMed ID: 9826220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetics of familial combined hyperlipidemia.
    Naukkarinen J; Ehnholm C; Peltonen L
    Curr Opin Lipidol; 2006 Jun; 17(3):285-90. PubMed ID: 16680034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients.
    Pihlajamäki J; Karjalainen L; Karhapää P; Vauhkonen I; Laakso M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):164-70. PubMed ID: 10634813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance.
    Pihlajamäki J; Valve R; Karjalainen L; Karhapää P; Vauhkonen I; Laakso M
    Eur J Clin Invest; 2001 Apr; 31(4):302-8. PubMed ID: 11298776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population].
    Wang C; Zhai F; Chi Y; Wang G
    Wei Sheng Yan Jiu; 2004 May; 33(3):317-20. PubMed ID: 15211802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance.
    Gertow K; Rosell M; Sjögren P; Eriksson P; Vessby B; de Faire U; Hamsten A; Hellenius ML; Fisher RM
    Eur J Clin Nutr; 2006 Dec; 60(12):1406-13. PubMed ID: 16788709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia.
    Campagna F; Montali A; Baroni MG; Maria AT; Ricci G; Antonini R; Verna R; Arca M
    Metabolism; 2002 Oct; 51(10):1298-305. PubMed ID: 12370850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
    Lee JC; Lusis AJ; Pajukanta P
    Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of insulin resistance in familial combined hyperlipidemia.
    Veerkamp MJ; de Graaf J; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Is obesity associated with a polymorphism Pro12Ala and Pro115Gln in the PPARgamma gene?].
    Bidzińska B; Demissie M; Tworowska U; Slezak R; Dobosz T; Milewicz A
    Pol Merkur Lekarski; 2004 Oct; 17(100):361-4. PubMed ID: 15690702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.
    Putt W; Palmen J; Nicaud V; Tregouet DA; Tahri-Daizadeh N; Flavell DM; Humphries SE; Talmud PJ;
    Hum Mol Genet; 2004 Aug; 13(15):1587-97. PubMed ID: 15175273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo.
    Ekholm M; Kahan T; Jörneskog G; Bröijersen A; Wallén NH
    Thromb Res; 2009 May; 124(1):110-5. PubMed ID: 19195683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Familial combined hyperlipidemia].
    Sasaki J
    Nihon Rinsho; 1999 Dec; 57(12):2776-81. PubMed ID: 10638212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia.
    Mar-Heyming R; Miyazaki M; Weissglas-Volkov D; Kolaitis NA; Sadaat N; Plaisier C; Pajukanta P; Cantor RM; de Bruin TW; Ntambi JM; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1193-9. PubMed ID: 18340007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fifty years studying hiperlipidemias: the case of familial combined hyperlipidemia].
    Aguilar-Salinas C; Gómez-Díaz R; Tusié-Luna MT
    Invest Clin; 2010 Jun; 51(2):145-58. PubMed ID: 20928976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
    Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
    Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.